新疆、上海支援湖北医疗队举行“三地四方”远程会诊 商讨新冠肺炎疑难病症解决方案

2020-03-09 黎明 央广网

据中央广播电视总台中国之声《全国新闻联播》报道,为提升支援湖北医疗队对疑难危重患者的救治率,3月6日,新疆医科大学附属第一医院和复旦大学附属中山医院医疗队专家,在武汉大学人民医院东院区,与乌鲁木齐、上

据中央广播电视总台中国之声《全国新闻联播》报道,为提升支援湖北医疗队对疑难危重患者的救治率,3月6日,新疆医科大学附属第一医院和复旦大学附属中山医院医疗队专家,在武汉大学人民医院东院区,与乌鲁木齐、上海两地的后方专家举行“三地四方”远程会诊,商讨医疗队遇到的新冠肺炎疑难病症的解决方案。

远程会诊中的两例病例,分别由新疆第一批支援湖北医疗队和复旦大学附属中山医院支援湖北医疗队提供。其中新疆医疗队负责的患者经过30天的救治,依然无法摆脱呼吸机辅助呼吸。新疆医科大学第一附属医院急救·创伤中心急诊内科主任、重症医疗组组长杨建中介绍,会诊中,樊嘉、葛均波院士以及两家医院的重症、呼吸、心血管等方面的专家,从影像、ICU、患者管理等方面提出了救治建议。杨建中表示:“对于重症患者要进行综合治疗,这包括很多方面。首先,是对于已知‘炎症风暴’(的治疗),比如通过人工肝和持续性肾脏替代治疗去治疗‘炎症风暴’,或者降低‘炎症风暴’对其带来的不利影响;第二,需要早期干预,比如像早期气道管理,早期呼吸支持,还有就是对于循环的评估,一定要针对每一位患者设定个体化的目标。以上这些,都是我们在讨论病例中所得到的专家们认可的建议和体会。”

此外,复旦大学附属中山医院副院长、上海第四批支援湖北医疗队领队朱畴文特别强调,想把这些经验充分运用到临床实践,就必须重视经验团队的经验分享。朱畴文表示:“应该说所有对于重症患者治疗的大方向、大目标,我们都是一致的。但是在临床上进行精细化操作,必然要依靠有经验的团队,大家共同商讨决定,而不是单纯说某个药和某个方法是可以用的。(所以)一定要根据临床一线的情况,充分相信这些经验丰富的医务工作者。”

据了解,新疆医科大学第一附属医院在上个世纪50年代建院初期,就得到了复旦大学附属中山医院的大力帮助。医院党委委员、新疆第一批支援湖北医疗队副领队刘志连表示,得益于对口援疆工作,两家医院建立对口帮扶,在医疗、科研、教学等方面一直保持密切交流。刘志连说:“我们跟上海方面有这么一个历史渊源,所以一直非常亲近,现在在湖北战场上没想到又在一个院区并肩战斗。这样一来就有很多业务的交集,情感的沟通,生活的交流。通过这种方式把后方的专家聚集起来,大家通过协调、讨论,给出建议,这对前方来讲,是解决遇到问题最好的一个方式。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1704711, encodeId=24b31e04711b8, content=<a href='/topic/show?id=5a7b3520265' target=_blank style='color:#2F92EE;'>#医疗队#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35202, encryptionId=5a7b3520265, topicName=医疗队)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd230811738, createdName=zll0635, createdTime=Wed Jul 29 20:04:16 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706724, encodeId=9fa71e0672490, content=<a href='/topic/show?id=c7fd2582e4b' target=_blank style='color:#2F92EE;'>#会诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25827, encryptionId=c7fd2582e4b, topicName=会诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39df31305194, createdName=1249859em48(暂无昵称), createdTime=Sat Jul 18 21:04:16 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988022, encodeId=fccc1988022f2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Jun 19 21:04:16 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027378, encodeId=593b102e3784e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 09 16:04:16 CST 2020, time=2020-03-09, status=1, ipAttribution=)]
    2020-07-29 zll0635
  2. [GetPortalCommentsPageByObjectIdResponse(id=1704711, encodeId=24b31e04711b8, content=<a href='/topic/show?id=5a7b3520265' target=_blank style='color:#2F92EE;'>#医疗队#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35202, encryptionId=5a7b3520265, topicName=医疗队)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd230811738, createdName=zll0635, createdTime=Wed Jul 29 20:04:16 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706724, encodeId=9fa71e0672490, content=<a href='/topic/show?id=c7fd2582e4b' target=_blank style='color:#2F92EE;'>#会诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25827, encryptionId=c7fd2582e4b, topicName=会诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39df31305194, createdName=1249859em48(暂无昵称), createdTime=Sat Jul 18 21:04:16 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988022, encodeId=fccc1988022f2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Jun 19 21:04:16 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027378, encodeId=593b102e3784e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 09 16:04:16 CST 2020, time=2020-03-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1704711, encodeId=24b31e04711b8, content=<a href='/topic/show?id=5a7b3520265' target=_blank style='color:#2F92EE;'>#医疗队#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35202, encryptionId=5a7b3520265, topicName=医疗队)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd230811738, createdName=zll0635, createdTime=Wed Jul 29 20:04:16 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706724, encodeId=9fa71e0672490, content=<a href='/topic/show?id=c7fd2582e4b' target=_blank style='color:#2F92EE;'>#会诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25827, encryptionId=c7fd2582e4b, topicName=会诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39df31305194, createdName=1249859em48(暂无昵称), createdTime=Sat Jul 18 21:04:16 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988022, encodeId=fccc1988022f2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Jun 19 21:04:16 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027378, encodeId=593b102e3784e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 09 16:04:16 CST 2020, time=2020-03-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1704711, encodeId=24b31e04711b8, content=<a href='/topic/show?id=5a7b3520265' target=_blank style='color:#2F92EE;'>#医疗队#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35202, encryptionId=5a7b3520265, topicName=医疗队)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd230811738, createdName=zll0635, createdTime=Wed Jul 29 20:04:16 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706724, encodeId=9fa71e0672490, content=<a href='/topic/show?id=c7fd2582e4b' target=_blank style='color:#2F92EE;'>#会诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25827, encryptionId=c7fd2582e4b, topicName=会诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39df31305194, createdName=1249859em48(暂无昵称), createdTime=Sat Jul 18 21:04:16 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988022, encodeId=fccc1988022f2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Jun 19 21:04:16 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027378, encodeId=593b102e3784e, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Mar 09 16:04:16 CST 2020, time=2020-03-09, status=1, ipAttribution=)]
    2020-03-09 公卫新人

    新冠肺炎,疫情何时才能消失

    0

拓展阅读

“阳没阳”?“什么株”?权威解读您关心的10大新冠疫情防治要点

朋友圈都在说北京病毒、广州病毒、成都病毒、武汉病毒...,而且各地所谓的病毒反应还不一样,甚至开玩笑说去挑个症状轻的病毒感染——这是真的吗?

“新武器”EIDD-2801有望助力抗击COVID-19

可以有效治疗COVID-19的化合物清单一天比一天长。

六大重要变化!新冠肺炎诊疗方案(试行第六版)

火速!新冠肺炎诊疗方案(试行第六版)出炉,六大重要变化都在这 来源:上海证券报2月19日,国家卫生健康委员会发布了《新型冠状病毒肺炎诊疗方案(试行第六版)》(简称「第六版」)。相比第五版,第六版在传播途径,临床表现、诊断标准、治疗等方面都有了更加细化、具体的说明,为防治新冠肺炎提供了更加明确的指南。敲黑板了!快来看看新冠肺炎诊疗有哪些重要的新变化?变化一:传播途径增加「密切接触」「气溶胶传播的可能